Kestra Medical TechnologiesKMTS
那斯達克 · USD
24.91
+0.39
(+1.59%)
收盤 12/12 04:59 (UTC+8)
盤後
24.50
24.50
(-1.65%)
12/12 04:59 (UTC+8)
Kestra Medical TechnologiesKMTS
24.91
+0.39
(+1.59%)
財務數據
損益表
- 0.08
- 0.10
- 0.13
- 0.15
- 0.15
- 0.17
- 0.19
- -
- 21.47
- 27.13
- 15.08
- -
- 14.20
- 12.41
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | |
營業收入淨額 | 19,371 | 17,233 | 15,090 | 14,710 | 12,782 | 10,054 | 8,277 |
營業成本 | 10,520 | 9,600 | 8,543 | 8,880 | 8,582 | 8,657 | 7,397 |
營業毛利 | 8,851 | 7,633 | 6,547 | 5,830 | 4,200 | 1,397 | 880 |
營業費用 | 37,729 | 55,845 | 27,148 | 24,964 | 22,631 | 21,746 | 20,826 |
研發費用 | 4,001 | 5,386 | 3,353 | 3,509 | 3,404 | 3,821 | 3,735 |
推銷及管理費用 | 33,728 | 50,459 | 23,795 | 21,455 | 19,227 | 17,925 | 17,091 |
非經常性項目費用 | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - |
營業利益 | -28,878 | -48,212 | -20,601 | -19,134 | -18,431 | -20,349 | -19,946 |
其他收入及費用 | 4,997 | -1,037 | - | - | - | - | - |
利息費用 | 1,912 | 1,760 | 1,783 | 1,402 | 1,874 | 1,935 | 1,651 |
稅前純益 | -25,793 | -51,009 | -21,741 | -20,613 | -20,316 | -22,311 | -21,605 |
所得稅 | 33 | 102 | 18 | 8 | 7 | -27 | 14 |
稅後純益 | -25,826 | -52,053 | -21,509 | -20,368 | -19,884 | -22,284 | -21,619 |
基本每股稅後盈餘(元) | -0.50 | -2.21 | -0.50 | - | -0.45 | - | -0.47 |
稀釋每股稅後盈餘(元) | -0.50 | -2.21 | -0.50 | - | -0.45 | - | -0.47 |
基本平均股數(千股) | 51304.00 | 24583.00 | 49533.00 | - | 49533.00 | - | 49533.00 |
稀釋平均股數(千股) | 51304.00 | 24583.00 | 49533.00 | - | 49533.00 | - | 49533.00 |
還原基本每股稅後盈餘(元) | -0.50 | -2.21 | -0.50 | - | -0.45 | - | -0.47 |
還原稀釋每股稅後盈餘(元) | -0.50 | -2.21 | -0.50 | - | -0.45 | - | -0.47 |
還原基本平均股數(千股) | 51,304 | 24,583 | 49,533 | - | 49,533 | - | 49,533 |
還原稀釋平均股數(千股) | 51,304 | 24,583 | 49,533 | - | 49,533 | - | 49,533 |
EBITDA(千元) | -21,384 | -47,986 | -17,820 | -17,089 | -15,628 | -16,874 | -16,591 |